LSD1

抑制剂选择性比较

LSD1产品

所有产品(8) LSD1抑制剂(8)

目录号	产品描述	文献引用	实验数据
S7237	OG-L002 OG-L002是一种有效的，特异性LSD1抑制剂，无细胞试验中IC50为20 nM，比作用于MAO-B和MAO-A选择性分别高36和69倍。	Sci Rep, 2021, 11(1):10285 Nat Genet, 2020, 52(10):1011-1017 Sci Rep, 2020, 10(1):377	Nalm6 cells were first treated with JIB-04 at 0.5 μM, OG-L002 at 10 μM or DMSO for 4 h, then 100 nM of dex or ethanol was added to the media for an additional 20 h. Lysates were analyzed by immunoblot with the indicated antibodies. Results shown are representative of three independent experiments.
S7574	GSK-LSD1 2HCl GSK-LSD1 2HCl是一种不可逆的选择性 LSD1抑制剂，IC50 为 16 nM，选择性比其它密切相关的FAD可利用酶(即 LSD2，MAO-A，MAO-B)高1000多倍。	Theranostics, 2022, 12(4):1500-1517 J Int Med Res, 2022, 50(1):3000605211067921 Cell Res, 2021, 1-13
S7795	Iadademstat (ORY-1001) 2HCl Iadademstat 2HCl (ORY-1001, RG-6016) 是一种口服具有活性的，选择性的，赖氨酸特异性脱甲基酶LSD1/KDM1A抑制剂，IC50为<20 nM，对相关的FAD依赖性氨基氧化酶具有高度选择性。Phase 1。	Nat Chem Biol, 2022, 10.1038/s41589-022-00996-7 Mol Psychiatry, 2022, 10.1038/s41380-022-01508-8 FASEB J, 2022, 36(1):e22122	Cells were exposed to drugs for 48 h or for the indicated times. Cell death and Dwm dissipation were determined by flow cytometric analyses of propidium iodide uptake or DiOC6(3) staining, respectively. Caspase 3/7 activity was determined using the fluorogenic substrate Ac-DEVD-AMC; relative caspase 3/7 activities are the ratio of treated cells to untreated cells.
S6722	Seclidemstat (SP-2577) Seclidemstat (SP-2577) 是一种有效的、口服的、可生物利用的 lysine-specific demethylase 1 (LSD1/KDM1A) 的抑制剂，IC50值为127 nM。 Seclidemstat（SP-2577）具有潜在的抗肿瘤活性。
S0356	Pulrodemstat (CC-90011) besylate Pulrodemstat (CC-90011) besylate (LSD1-IN-7 benzenesulfonate) 是一种有效的口服活性 lysine specific demethylase-1 (LSD1) 抑制剂，并被发现在多种肿瘤治疗中有效。
S7796	GSK2879552 2HCl GSK2879552 2HCl 是一种有效的、选择性的、具有生物口服活性的、不可逆的LSD1的抑制剂，Kiapp=1.7 μM。	Nat Chem Biol, 2022, 10.1038/s41589-022-00996-7 Mol Cell, 2021, S1097-2765(21)01037-6 J Neurosci, 2021, JN-RM-3102-20	Effects of LSD1 inhibitors in acute myeloid leukaemia cells. Cells were exposed to drugs for 48 h or for the indicated times. Cell death and Dwm dissipation were determined by flow cytometric analyses of propidium iodide uptake or DiOC6(3) staining, respectively. Caspase 3/7 activity was determined using the fluorogenic substrate Ac-DEVD-AMC; relative caspase 3/7 activities are the ratio of treated cells to untreated cells. Means±SEM of each two (caspase 3/7 activity) or three (flow cytometric analyses) separate measurements are shown.
S7680	SP2509 SP2509 (HCI-2509)是一种选择性histone demethylase LSD1抑制剂，IC50为 13 nM，对MAO-A，MAO-B，乳酸脱氢酶和葡萄糖氧化酶没有活性。SP2509 可诱导凋亡并促进自噬。	Biomedicines, 2022, 10(3)638 Invest Ophthalmol Vis Sci, 2022, 63(3):20 Cell Death Dis, 2021, 12(11):993	Cells were exposed to drugs for 48 h or for the indicated times. Cell death and Dwm dissipation were determined by flow cytometric analyses of propidium iodide uptake or DiOC6(3) staining, respectively. Caspase 3/7 activity was determined using the fluorogenic substrate Ac-DEVD-AMC; relative caspase 3/7 activities are the ratio of treated cells to untreated cells.
S8438	T-3775440 HCl T-3775440 HCl是一种不可逆的LSD1抑制剂。相对于其他单胺氧化酶，它对LSD1具有高选择性，IC50为2.1 nM。

目录号	产品描述	文献引用	实验数据
S7237	OG-L002 OG-L002是一种有效的，特异性LSD1抑制剂，无细胞试验中IC50为20 nM，比作用于MAO-B和MAO-A选择性分别高36和69倍。	Sci Rep,2021, 11(1):10285 Nat Genet,2020, 52(10):1011-1017 Sci Rep,2020, 10(1):377	Nalm6 cells were first treated with JIB-04 at 0.5 μM, OG-L002 at 10 μM or DMSO for 4 h, then 100 nM of dex or ethanol was added to the media for an additional 20 h. Lysates were analyzed by immunoblot with the indicated antibodies. Results shown are representative of three independent experiments.
S7574	GSK-LSD1 2HCl GSK-LSD1 2HCl是一种不可逆的选择性 LSD1抑制剂，IC50 为 16 nM，选择性比其它密切相关的FAD可利用酶(即 LSD2，MAO-A，MAO-B)高1000多倍。	Theranostics,2022, 12(4):1500-1517 J Int Med Res,2022, 50(1):3000605211067921 Cell Res,2021, 1-13
S7795	Iadademstat (ORY-1001) 2HCl Iadademstat 2HCl (ORY-1001, RG-6016) 是一种口服具有活性的，选择性的，赖氨酸特异性脱甲基酶LSD1/KDM1A抑制剂，IC50为<20 nM，对相关的FAD依赖性氨基氧化酶具有高度选择性。Phase 1。	Nat Chem Biol,2022, 10.1038/s41589-022-00996-7 Mol Psychiatry,2022, 10.1038/s41380-022-01508-8 FASEB J,2022, 36(1):e22122	Cells were exposed to drugs for 48 h or for the indicated times. Cell death and Dwm dissipation were determined by flow cytometric analyses of propidium iodide uptake or DiOC6(3) staining, respectively. Caspase 3/7 activity was determined using the fluorogenic substrate Ac-DEVD-AMC; relative caspase 3/7 activities are the ratio of treated cells to untreated cells.
S6722	Seclidemstat (SP-2577) Seclidemstat (SP-2577) 是一种有效的、口服的、可生物利用的 lysine-specific demethylase 1 (LSD1/KDM1A) 的抑制剂，IC50值为127 nM。 Seclidemstat（SP-2577）具有潜在的抗肿瘤活性。
S0356	Pulrodemstat (CC-90011) besylate Pulrodemstat (CC-90011) besylate (LSD1-IN-7 benzenesulfonate) 是一种有效的口服活性 lysine specific demethylase-1 (LSD1) 抑制剂，并被发现在多种肿瘤治疗中有效。
S7796	GSK2879552 2HCl GSK2879552 2HCl 是一种有效的、选择性的、具有生物口服活性的、不可逆的LSD1的抑制剂，Kiapp=1.7 μM。	Nat Chem Biol,2022, 10.1038/s41589-022-00996-7 Mol Cell,2021, S1097-2765(21)01037-6 J Neurosci,2021, JN-RM-3102-20	Effects of LSD1 inhibitors in acute myeloid leukaemia cells. Cells were exposed to drugs for 48 h or for the indicated times. Cell death and Dwm dissipation were determined by flow cytometric analyses of propidium iodide uptake or DiOC6(3) staining, respectively. Caspase 3/7 activity was determined using the fluorogenic substrate Ac-DEVD-AMC; relative caspase 3/7 activities are the ratio of treated cells to untreated cells. Means±SEM of each two (caspase 3/7 activity) or three (flow cytometric analyses) separate measurements are shown.
S7680	SP2509 SP2509 (HCI-2509)是一种选择性histone demethylase LSD1抑制剂，IC50为 13 nM，对MAO-A，MAO-B，乳酸脱氢酶和葡萄糖氧化酶没有活性。SP2509 可诱导凋亡并促进自噬。	Biomedicines,2022, 10(3)638 Invest Ophthalmol Vis Sci,2022, 63(3):20 Cell Death Dis,2021, 12(11):993	Cells were exposed to drugs for 48 h or for the indicated times. Cell death and Dwm dissipation were determined by flow cytometric analyses of propidium iodide uptake or DiOC6(3) staining, respectively. Caspase 3/7 activity was determined using the fluorogenic substrate Ac-DEVD-AMC; relative caspase 3/7 activities are the ratio of treated cells to untreated cells.
S8438	T-3775440 HCl T-3775440 HCl是一种不可逆的LSD1抑制剂。相对于其他单胺氧化酶，它对LSD1具有高选择性，IC50为2.1 nM。

Tags: LSD1 inhibitor | LSD1 modulator | LSD1 chemical